3-[(6-amino-9H-purin-9-yl)methyl]-N,8-dimethyl-N-[(1-methylpyrrolidin-2-yl)methyl]quinolin-2-amine | 1365615-11-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 3-[(6-amino-9H-purin-9-yl)methyl]-N,8-dimethyl-N-[(1-methylpyrrolidin-2-yl)methyl]quinolin-2-amine
• 英文别名: 3-[(6-aminopurin-9-yl)methyl]-N,8-dimethyl-N-[(1-methylpyrrolidin-2-yl)methyl]quinolin-2-amine
• CAS: 1365615-11-7
• 化学式: C₂₃H₂₈N₈
• 分子量: 416.529
• InChiKey: VFXTZCPBDJHFLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  31
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  89
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Use of Inhibitors of the Activity or Function of PI3K
  申请人：NOVARTIS AG

  公开号：US20150342951A1

  公开（公告）日：2015-12-03

  The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.

  该发明涉及PI3K抑制剂的新用途，其中所述抑制剂对PI3K同工酶δ具有抑制作用，用于治疗患有疟疾、利什曼病、锥虫病、弓形虫病和/或神经囊虫病等疾病或紊乱的受试者的免疫病理学，通过对感染受试者的TLR9的功能抑制。
• [EN] INHIBITORS OF PI3K-DELTA AND METHODS OF THEIR USE AND MANUFACTURE<br/>[FR] INHIBITEURS DE PI3K-? ET LEURS PROCÉDÉS D'UTILISATION ET FABRICATION
  申请人：EXELIXIS INC

  公开号：WO2012037204A1

  公开（公告）日：2012-03-22

  The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.

  该发明涉及公式I的化合物：以及这些化合物的药用盐或溶剂合物，以及制备和使用这些化合物的方法。
• Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
  申请人：Leahy James William

  公开号：US20140045825A1

  公开（公告）日：2014-02-13

  The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.

  该发明涉及式I的化合物：以及其药学上可接受的盐或溶剂，以及制备和使用该化合物的方法。
• Inhibitors of PI3K-delta and methods of their use and manufacture
  申请人：Exelixis, Inc.

  公开号：US10053470B2

  公开（公告）日：2018-08-21

  The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof as well as methods of making and using the compounds.

  本发明涉及式 I：化合物及其药学上可接受的盐或溶液，以及制造和使用这些化合物的方法。
• INHIBITORS OF PI3K-DELTA AND METHODS OF THEIR USE AND MANUFACTURE
  申请人：Exelixis, Inc.

  公开号：EP2616442A1

  公开（公告）日：2013-07-24